TITLE:
Prevalence and Factors Associated with Dry Eyes Syndrome in Glaucomatous Patients on Anti-Glaucoma Eye Drops Followed up at the Garoua Regional Hospital-Northern Cameroon
AUTHORS:
Josiane Mare Njoya, Dodo Balkissou, Bimingo Noelle Bra’ Eyatcha, Viola Dohvoma, Yannick Bilong, Godefroy Koki
KEYWORDS:
Dry Eyes, Glaucoma, Conservative Eye Drops Médications, Garoua-Cameroon
JOURNAL NAME:
Open Journal of Ophthalmology,
Vol.14 No.3,
August
23,
2024
ABSTRACT: Background: Dry eye and glaucoma are two common pathologies in the elderly, and are very often associated. This association suggests a link between them and between their treatments. Our purpose for this study is to determine the prevalence of dry eye in our glaucoma patients treated with eye drops and deduce the factors associated with it. Patients and Methods: We conducted a cross-sectional, analytical study from October 2022 to September 2023 in the ophthalmology department of Garoua Regional Hospital in glaucoma patients aged over 15 years able to answer the Ocular Surface Disease Index (OSDI) questionnaires and treated with antiglaucoma eye drops for more than 3 months. These patients underwent a complete ophthalmological examination and a tear film break-up time test. Results: A total of 73 patients (146 eyes) were examined. The average age of the patients was 47.2 ± 16.5 years, with a male predominance of 54.8%. The prevalence of dry eye syndrome in our patients according to the OSDI score was 56.2% (95% CI) (44.8; 67.6). The prevalence of dry eye syndrome on clinical examination of the BUT in the right eye was 83.7% (95% CI) (75.1; 92.1) and 79.4% (70.2; 88.7) in the left eye. The duration of antiglaucoma treatment was the factor associated with dry eye syndrome (p